Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
311 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
1 Not yet recruiting SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I
Conditions: Urinary Bladder Neoplasms;   Urologic Neoplasms;   Urogenital Neoplasms;   Neoplasms;   Neoplasms by Site;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
2 Recruiting A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Intervention: Drug: Betmiga®
3 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
6 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Unknown  Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: Paclitaxel, nanoparticle albumin-bound
9 Not yet recruiting Detection of K14 in Bladder Cancer With a Non Invasive Technique
Condition: Bladder Cancer
Intervention:
10 Recruiting Transvaginal Treatment of Symptomatic Cystocele Grade II-III
Condition: Cystocele
Intervention: Device: cystocele repair with biomesh soft prolaps and endofast reliant
11 Recruiting Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors
Condition: Neoplasm of Lateral Wall of Urinary Bladder
Interventions: Device: Bipolar transurethral resection of the urinary bladder (PlasmaKinetic, Gyrus, Fresenius);   Device: Monopolar transurethral resection of the urinary bladder (Storz GmbH &Co., Erbotom, Purisole)
12 Unknown  Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder
Condition: Overactive Bladder
Intervention: Behavioral: Health education intervention (HEI)
13 Recruiting Safety and Efficacy Study of Cancer Immunotherapeutic MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
Condition: Urinary Bladder Neoplasms
Interventions: Biological: recMAGE-A3 + AS15 ASCI;   Biological: Placebo
14 Recruiting Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Procedure: Unilateral electrode placement and testing;   Procedure: Bilateral electrode placement and testing
15 Recruiting Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C
16 Recruiting Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Other: Observation
17 Recruiting Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
Conditions: Prostate Cancer;   Bladder Cancer;   Kidney Cancer
Intervention: Drug: Ferumoxytol
18 Recruiting Familial and Atypical Urothelial Cancer Registry
Conditions: Urothelial Cancer;   Renal Pelvis Cancer;   Ureter Cancer;   Bladder Cancer
Interventions: Other: saliva sample and questionaire;   Other: saliva sample, questionaire
19 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
20 Recruiting Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy
Conditions: Bladder Cancer;   Entire Ileal Conduit;   Urinary Bladder Cancer
Intervention: Other: Prehabilitation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years